A SYSTEMATIC STUDY AND META-ANALYSIS OF TUBERCULOSIS INFECTION PREVALENCE IN INDIA
DOI:
https://doi.org/10.51168/sjhrafrica.v5i12.1509Keywords:
Systematic Review, Tuberculosis, Tuberculin Skin Test, Interferon Gamma Release Assay, TB infectionAbstract
Background and objectives
One of the most common infectious agent-related causes of death worldwide is tuberculosis (TB), which is caused by Mycobacterium tuberculosis. Nevertheless, not much is currently understood regarding the prevalence of TBI in India's various risk groups. The purpose of this systematic review and meta-analysis was to calculate the prevalence of TBI in India by risk categories, sociodemographic profile, and geographic location.
Methods
Through a comprehensive analysis, this study investigated the prevalence of tuberculosis infection (TBI) in India between 2013 and 2022. Following the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), 70 papers were examined using databases such as Scopus, CINAHL, EMBASE, and MEDLINE. The holistic method provided a detailed picture of the prevalence of TBI in India by using a variety of languages and study settings.
Results
70 research studies, including approximately 40 prevalence studies and approximately 30 long-term studies, were included in this paper after a review of 10,510 papers. Based on population-based sample studies, the total prevalence of tuberculosis infection (TBI) in India was 40.79 %. When highly sensitive populations were excluded from the general population, this percentage remained constant at 35.99%. T
Conclusion
The current thorough investigation demonstrated the high prevalence of TB infections in India, which corresponded with proactive TB infections and suggested a possible transition from latent to active TB. Notably, people living in the southern regions of the country were more likely to experience this possibility.
Recommendation
To assist efficient programmatic management in the pursuit of India's TB elimination targets, this study suggests giving priority to Tuberculosis Preventive Treatment (TPT) in areas with a high prevalence of Tuberculosis Infection (TBI) and promoting a "No test, treat only" approach for resource efficiency.
References
World Health Organization. The END TB strategy; 2015. Available from: https://apps.who.int/iris/bitstream/handle/10665/331326/ WHO-HTM-TB-2015.19-eng.pdf?sequence=1&isAllowed=y, accessed on February 20, 2023
World Health Organization. WHO consolidated guidelines on tuberculosis: Module 1: Prevention. Tuberculosis preventive treatment. Geneva: WHO; 2020. https://doi.org/10.30978/TB2021-2-86
World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: Treatment: Drug-susceptible tuberculosis treatment. Geneva: WHO; 2022.
Blumberg HM, Ernst JD. The challenge of latent TB infection. JAMA 2016; 316 : 931-3. https://doi.org/10.1001/jama.2016.11021
Ministry of Health and Family Welfare, Government of India. INDIA TB REPORT 2022. Available from: https://tbcindia. gov.in/WriteReadData/IndiaTBReport2022/TBAnnaulReport 2022.pdf, accessed on February 20, 2023.
Indian Council of Medical Research. Central TB Division, Ministry of Health and Family Welfare, Government of India, National TB prevalence survey in India. Available from: https://tbcindia.gov.in/showfile.php?lid=3659, accessed on February 20, 2023.
Rajpal S, Arora VK. Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question". Indian J Tuberc 2020; 67: S43-7. https://doi.org/10.1016/j.ijtb.2020.09.028
Sharma N, Basu S, Chopra KK. Achieving TB elimination in India: The role of latent TB management. Indian J Tuberc 2019; 66: 30-3. https://doi.org/10.1016/j.ijtb.2018.10.006
Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. National strategic plan for tuberculosis elimination 2017-2025. Available from: https://tbcindia.gov.in/WriteReadData/NSP Draft 20.02.2017 1.pdf, accessed on February 20, 2023.
Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, et al. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet 2019; 393: 1331-84. https://doi.org/10.1016/S0140-6736(19)30024-8
Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, et al. The growing importance of tuberculosis preventive therapy and how research and innovation can enhance its implementation on the ground. Trop Med Infect Dis 2020; 5: 61. https://doi.org/10.3390/tropicalmed5020061
Agarwal SK, Singh UB, Zaidi SH, Gupta S, Pandey RM. Comparison of interferon-gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance hemodialysis. Indian J Med Res 2015; 141: 463-8 https://doi.org/10.4103/0971-5916.159297
Arya S, Kumar SK, Nath A, Kapoor P, Aggarwal A, Misra R, et al. The synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting. PLoS One 2018; 13 : e0204429. https://doi.org/10.1371/journal.pone.0204429
Bajgai P, Sharma K, Bansal R, Gupta N, Sharma A, Gupta A. Detection of Mycobacterium tuberculosis genome in the subretinal fluid of patients with latent tuberculosis infection. Ocul Immunol Inflamm 2016; 24: 615-20. https://doi.org/10.3109/09273948.2015.1063670
Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, et al. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infect Dis 2020; 20: 96. https://doi.org/10.1186/s12879-020-4800-y
Benachinmardi K, Sampath S, Rao M. Evaluation of a new interferon-gamma release assay, in comparison to tuberculin skin tests and quantifiers tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting. Int J Mycobacteriol 2021; 10: 142-8. https://doi.org/10.4103/ijmy.ijmy_44_21
Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, et al. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One 2018; 13 : e0199360. https://doi.org/10.1371/journal.pone.0199360
Aravindhan V, Bobhate A, Sathishkumar K, Patil A, Kumpatla S, Viswanathan V. Unique reciprocal association seen between latent tuberculosis infection and diabetes is due to immunoendocrine modulation (DM-LTB-1). Front Microbiol 2022; 13: 884374. https://doi.org/10.3389/fmicb.2022.884374
Bapat PR, Husain AA, Daginawala HF, Agrawal NP, Panchbhai MS, Satav AR, et al. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India. J Infect Public Health 2015; 8: 329-40. https://doi.org/10.1016/j.jiph.2015.02.003
Benachinmardi KK, Sangeetha S, Rao M, Prema R. Validation and clinical application of interferon-gamma release assay for diagnosis of latent tuberculosis infection in children. Int J Appl Basic Med Res 2019; 9: 241-5. https://doi.org/10.4103/ijabmr.IJABMR_86_19
Boddu D, Verghese VP, Michael JS, Chacko A, Jeyaseelan V. Utility of QuantiFERON(®)-TB gold In-Tube test compared with tuberculin skin test in diagnosing tuberculosis in Indian children with malnutrition. Indian J Med Microbiol 2019; 37: 433-7. https://doi.org/10.4103/ijmm.IJMM_19_227
Agarwal SK, Singh UB, Zaidi SH, Gupta S, Pandey RM. Comparison of interferon-gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance hemodialysis. Indian J Med Res 2015; 141: 463-8. https://doi.org/10.4103/0971-5916.159297
Agarwal S, Das SK, Agarwal GG, Srivastava R. Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: Implications on Anti-TNF therapies. Interdiscip Perspect Infect Dis 2014; 2014: 430134. https://doi.org/10.1155/2014/430134
Christopher DJ, Shankar D, Datey A, Zwerling A, Pai M. Safety of the two-step tuberculin skin test in Indian health care workers. Int J Mycobacteriol 2014; 3: 247-51. https://doi.org/10.1016/j.ijmyco.2014.10.004
Dabhi PA, Thangakunam B, Gupta R, James P, Thomas N, Naik D, et al. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital. PLoS One 2020; 15 : e0233385. https://doi.org/10.1371/journal.pone.0233385
Dolla CK, Padmapriyadarsini C, Thiruvengadam K, Lokhande R, Kinikar A, Paradkar M, et al. Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? Trans R Soc Trop Med Hyg 2019; 113 : 632-40 https://doi.org/10.1093/trstmh/trz049
Faujdar SS, Singh U, Kumar S, Mehrishi P, Sharma A, Dutta A. Mantoux test defaulters in rural population attending tertiary care hospital in a tuberculosis endemic area. J Family Med Prim Care 2022; 11: 677-9 https://doi.org/10.4103/jfmpc.jfmpc_1355_21
Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, et al. Feasibility of identifying household contacts of Rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clin Infect Dis 2020; 70: 425-35. https://doi.org/10.1093/cid/ciz235
Jain SK, Ordonez A, Kinikar A, Gupte N, Thakar M, Mave V, et al. Pediatric tuberculosis in young children in India: A prospective study. Biomed Res Int 2013; 2013: 783698. https://doi.org/10.1155/2013/783698
Janagond AB, Ganesan V, Vijay Kumar GS, Ramesh A, Anand P, Mariappan M. Screening of healthcare workers for latent tuberculosis infection in a Tertiary Care Hospital. Int J Mycobacteriol 2017; 6: 253-7. https://doi.org/10.4103/ijmy.ijmy_82_17
Dayal R, Agarwal D, Bhatia R, Bipin C, Yadav NK, Kumar S, et al. Tuberculosis burden among household pediatric contacts of adult tuberculosis patients. Indian J Pediatr 2018; 85 : 867-71. https://doi.org/10.1007/s12098-018-2661-9
Dinkar PK, Kumar S, Kumar S, Verma SK, Kumar S. To study the prevalence of latent tuberculosis infection among medical students. Indian J Community Health 2022; 34: 5-9. https://doi.org/10.47203/IJCH.2022.v34i02.025
Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, et al. High prevalence of active and latent tuberculosis in children and adolescents in Tibetan schools in India: The Zero TB kids initiative in Tibetan refugee children. Clin Infect Dis 2019; 69: 760-8. https://doi.org/10.1093/cid/ciy987
Girish S, Kinikar A, Pardesh G, Shelke S, Basavaraj A, Chandanwale A, et al. Utility of the interferon-gamma release assay for latent tuberculosis infection screening among Indian health-care workers. Indian J Community Med 2021; 46: 281-4.
Gupta A, Sural S, Gupta A, Rousa S, Koner BC, Bhalotra A, et al. Positive QuantiFERON test and the severity of COVID-19 disease: A prospective study. Indian J Tuberc 2021; 68: 474-80. https://doi.org/10.1016/j.ijtb.2020.12.013
James PM, Ganaie FA, Kadahalli RL. The performance of quantifier-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population. J Int Assoc Provid AIDS Care 2014; 13: 47-55. https://doi.org/10.1177/2325957412469687
Jenum S, Selvam S, Mahelai D, Jesuraj N, Cárdenas V, Kenneth J, et al. Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India. Pediatr Infect Dis J 2014; 33 : e260-9. https://doi.org/10.1097/INF.0000000000000399
Chauhan S, Gahalaut P, Rathi AK. Tuberculin Skin Test, chest radiography and contact screening in children ≤5 y: Relevance in Revised National Tuberculosis Control Programme (RNTCP). Indian J Pediatr 2013; 80 : 276-80. https://doi.org/10.1007/s12098-012-0792-y
Mukherjee A, Saini S, Kabra SK, Gupta N, Singh V, Singh S, et al. Effect of micronutrient deficiency on QuantiFERONTB Gold In-Tube test and tuberculin skin test in the diagnosis of childhood Intrathoracic tuberculosis. Eur J Clin Nutr 2014; 68 : 38-42 https://doi.org/10.1038/ejcn.2013.216
Kashyap RS, Nayak AR, Gaherwar HM, Husain AA, Shekhawat SD, Jain RK, et al. Latent TB infection diagnosis in a population exposed to TB subjects in close and poor ventilated high TB endemic zone in India. PLoS One 2014; 9 : e89524. https://doi.org/10.1371/journal.pone.0089524
Kinikar A, Chandanwale A, Kadam D, Joshi S, Basavaraj A, Pardeshi G, et al. High risk for latent tuberculosis infection among medical residents and nursing students in India. PLoS One 2019; 14 : e0219131. https://doi.org/10.1371/journal.pone.0219131
Vijay Kumar GS, Gopalakrishnan R. Detection of latent tuberculosis infection in nursing students by combined TST and IGRA serial testing. J Med Sci Clin Res 2014; 2: 567-74.
Kumar P, Vuyyuru SK, Kante B, Sahu P, Goyal S, Madhu D, et al. A stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in a tuberculosis endemic region. Aliment Pharmacol Ther 2022; 55 : 1431-40. https://doi.org/10.1111/apt.16839
Madan K, Sryma PB, Pattnaik B, Mittal S, Tiwari P, Hadda V, et al. Clinical profile of 327 patients with Sarcoidosis in India: An Ambispective cohort study in a Tuberculosis (TB) endemic population. Lung India 2022; 39: 51-7. https://doi.org/10.4103/lungindia.lungindia_960_20
Syed Ahamed Kabeer B, Paramasivam P, Raja A. Interferon-gamma and interferon-gamma inducible protein-10 in detecting tuberculosis infection. J Infect 2012; 64: 573-9. https://doi.org/10.1016/j.jinf.2012.02.013
Kashyap RS, Nayak AR, Husain AA, Shekhawat SD, Satav AR, Jain RK, et al. Impact of socioeconomic status and living condition on latent tuberculosis diagnosis among the tribal population of Melghat: A cohort study. Lung India 2016; 33: 372-80. https://doi.org/10.4103/0970-2113.184868
Kaul S, Nair V, Birla S, Dhawan S, Rathore S, Khanna V, et al. Latent tuberculosis infection diagnosis among household contacts in a high tuberculosis-burden area: A comparison between transcript signature and interferon-gamma release assay. Microbiol Spectr 2022; 10: e0244521. https://doi.org/10.1128/spectrum.02445-21
Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Jose M, Sathishkumar A, et al. Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear-positive pulmonary tuberculosis patients in South India. Trop Med Int Health 2021; 26: 1645-51. https://doi.org/10.1111/tmi.13693
Madan M, Baldwa B, Raja A, Tyagi R, Dwivedi T, Mohan A, et al. Impact of latent tuberculosis on severity and outcomes in admitted COVID-19 patients. Cureus 2021; 13 : e19882. https://doi.org/10.7759/cureus.19882
Malaviya AN, Aggarwal VK, Rawat R, Baghel S, Thakran R, Zaheer Q, et al. Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease-modifying anti-rheumatic drugs in India, a high-burden TB country: The importance of Mantoux and Quantiferon-TB Gold tests. Int J Rheum Dis 2018; 21: 1563-71. https://doi.org/10.1111/1756-185X.13261
Kumar MG, Joseph B, Goud BR, Joseph M, Rajitha M. Risk of tuberculosis infection among healthcare workers in a tertiary care hospital in Bengaluru City. Indian J Occup Environ Med 2019; 23: 83-9. https://doi.org/10.4103/ijoem.IJOEM_269_18
Malaviya AN, Thakaran R, Rawat R, Kapoor S, Garg S, Baghel SS, et al. Real-life experience of a screening strategy for latent tuberculosis before treatment with biologicals in Indian patients with rheumatic diseases. Indian J Rheumatol 2018; 13: 233-9 https://doi.org/10.4103/injr.injr_66_18
Mathad JS, Bhosale R, Sangar V, Mave V, Gupte N, Kanade S, et al. Pregnancy differentially impacts the performance of latent tuberculosis diagnostics in a high-burden setting. PLoS One 2014; 9 : e92308. https://doi.org/10.1371/journal.pone.0092308
Mave V, Chandrasekaran P, Chavan A, Shivakumar SVBY, Danasekaran K, Paradkar M, et al. Infection-free "resisters" among household contacts of adult pulmonary tuberculosis. PLoS One 2019; 14 : e0218034. https://doi.org/10.1371/journal.pone.0218034
Munisankar S, Rajamanickam A, Balasubramanian S, Muthusamy S, Menon PA, Ahamed SF, et al. Prevalence of proximate risk factors of active tuberculosis in latent tuberculosis infection: A cross-sectional study from South India. Front Public Health 2022; 10: 1011388. https://doi.org/10.3389/fpubh.2022.1011388
Narasimhan P, MacIntyre CR, Mathai D, Wood J. High rates of latent TB infection in contacts and the wider community in South India. Trans R Soc Trop Med Hyg 2017; 111 : 55-61. https://doi.org/10.1093/trstmh/trx016
Neema S, Sandhu S, Mukherjee S, Vashisht D, Vendhan S, Sinha A, et al. Comparison of interferon-gamma release assay and tuberculin skin test for diagnosis of latent tuberculosis in Psoriasis Patients Planned for Systemic Therapy. Indian J Dermatol 2022; 67 : 19-25. https://doi.org/10.4103/ijd.ijd_681_21
Mantri AK, Meena P, Puri AS, Kumar A, Sachdeva S, Srivastava S, et al. Comparison of interferon-gamma release assay and tuberculin skin test for the screening of latent tuberculosis in inflammatory bowel disease patients: Indian Scenario. Tuberc Res Treat 2021; 2021: 6682840. https://doi.org/10.1155/2021/668284
Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, et al. Quantitative IFN-γ and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women. Am J Respir Crit Care Med 2016; 193 : 1421-8. https://doi.org/10.1164/rccm.201508-1595OC
Mishra S, Singh SK, Mohan U, Sahu R, Verma AK. Risk factors associated with tuberculosis infection among household children contacts of sputum smear-positive tuberculosis cases. Indian J Community Health 2017; 29: 162-7. https://doi.org/10.47203/IJCH.2017.v29i02.007
Neema S, Radhakrishnan S, Dabbas D, Vasudevan B. Latent tuberculosis in psoriasis patients planned for systemic therapy - A prospective observational study. Indian Dermatol Online J 2021; 12 : 429-32. https://doi.org/10.4103/idoj.IDOJ_698_20
Murthy M, Selvam S, Jesuraj N, Bennett S, Doherty M, Grewal HM, et al. Two-step tuberculin skin testing in school-going adolescents with initial 0-4 millimeter responses in a high tuberculosis prevalence setting in South India. PLoS One 2013; 8 : e71470. https://doi.org/10.1371/journal.pone.0071470
Pattnaik B, Pb S, Verma M, Kumar S, Mittal S, Arava S, et al. Patient profile and comparison of three diagnostic criteria for cardiac sarcoidosis in a tuberculosis endemic population. Sarcoidosis Vasc Diffuse Lung Dis 2022; 38 : e2021040.
Pandey A, Warade JP. Role of QuantiFERON-TB QuantiFERON TB gold in the diagnosis of tuberculosis. IAIM 2014; 1: 9-12
Prabhavathi M, Kabeer BS, Deenadayalan A, Raja A. Role of QuantiFERON-TB gold antigen-specific IL-1β in the diagnosis of active tuberculosis. Med Microbiol Immunol 2015; 204: 567-74. https://doi.org/10.1007/s00430-014-0382-x
Patil S, Phutane M, Mundkar S. Role of tuberculin skin test in latent tuberculosis infection in HIV patients in a tertiary care hospital of India. J Transl Intern Med 2014; 2 : 136-42. https://doi.org/10.4103/2224-4018.141841
Ramaraj SM, Nagendra K, Gopal G, Majgi SM. There is a need for different cutoff values for reading Mantoux Test with 2TU and 5TU PPD. Indian J Pediatr 2017; 84 : 677-80. https://doi.org/10.1007/s12098-017-2363-8
Reddy D, Ma Y, Lakshminarayanan S, Sahu S, White LF, Reshma A, et al. Severe undernutrition in children affects tuberculin skin test performance in Southern India. PLoS One 2021; 16 : e0250304. https://doi.org/10.1371/journal.pone.0250304
Shah I, Raut V, Shetty NS. Interpretation of tuberculin skin test in Bacillus Calmette - Guerin-Vaccinated children. Med J DY Patil Vidyapeeth 2021; 14 : 512-6. https://doi.org/10.4103/mjdrdypu.mjdrdypu_307_20
Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D. Comparison of TST and IGRA in the diagnosis of latent tuberculosis infection in a high TB-Burden setting. PLoS One 2017; 12 : e0169539. https://doi.org/10.1371/journal.pone.0169539
Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, et al. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS One 2020; 15 : e0236743. https://doi.org/10.1371/journal.pone.0236743
Prabhavathi M, Ahamed Kabeer BS, Deenadayalan A, Raja A. In vitro QuantiFERON-TB gold antigen-specific interleukin1beta to diagnose TB among HIV-positive subjects. Tuberculosis (Edinb) 2016; 96: 27-30. https://doi.org/10.1016/j.tube.2015.10.005
Rajamanickam A, Kumar NP, Padmapriyadarsini C, Nancy A, Selvaraj N, Karunanithi K, et al. Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine, and acute phase responses in seropositive SARSCoV-2 infection. J Infect 2021; 83: 339-46. https://doi.org/10.1016/j.jinf.2021.07.029
Rajalakshmi KV, Viknesh Prabu A. Prevalence of latent tuberculosis infection in type 2 diabetic and non-diabetic individuals. J Med Sci Clin Res 2017; 5: 23617-23. https://doi.org/10.18535/jmscr/v5i6.135
Shah I, Kathwate J, Shetty NS. Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus CalmetteGuerin-vaccinated children. Lung India 2020; 37: 24-9. https://doi.org/10.4103/lungindia.lungindia_304_19
Sawhney N, Mehta S, Shinu P, Singh V. Prevalence of Latent Tuberculosis infection among hospital workers in a tertiary care referral center. Int J Adv Health Sci 2015; 2: 585-91.
Shivakumar SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, et al. Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: Is it time to screen them all? Int J Tuberc Lung Dis 2018; 22: 686-94. https://doi.org/10.5588/ijtld.17.0598
Srivastava G, Faridi MMA, Gupta SS. Tubercular infection in children living with adults receiving Directly Observed Treatment Short Course (DOTS): A follow-up study. BMC Infect Dis 2020; 20: 720 https://doi.org/10.1186/s12879-020-05449-x
Singh J, Sankar MM, Kumar S, Gopinath K, Singh N, Mani K, et al. Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a Peri-Urban population of South Delhi, India. PLoS One 2013; 8 : e69730. https://doi.org/10.1371/journal.pone.0069730
Surve S, Bhor V, Naukariya K, Begum S, Munne K, Tipre P, et al. Discordance between TST and QFT-TBGold plus for latent tuberculosis screening among under-five children: An interim analysis. J Trop Pediatr 2021; 67 : fmab103. https://doi.org/10.1093/tropej/fmab103
Thomas L, Verghese VP, Chacko A, Michael JS, Jeyaseelan V. Accuracy and agreement of the Tuberculin Skin Test (TST) and the QuantiFERON-TB Gold In-tube test (QFT) in the diagnosis of tuberculosis in Indian children. Indian J Med Microbiol 2022; 40: 109-12. https://doi.org/10.1016/j.ijmmb.2021.05.022
Vyas S, Thangakunam B, Gupta R, Michael JS, Christopher DJ. Interferon-gamma release assay and tuberculin skin test positivity in Sarcoidosis. Lung India 2015; 32: 91-2. https://doi.org/10.4103/0970-2113.148467
Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: A Re-estimation using mathematical modeling. PLoS Med 2016; 13: e1002152. https://doi.org/10.1371/journal.pmed.1002152
Yelk Woodruff R, Hill A, Marks S, Navin T, Miramontes R. Estimated latent tuberculosis infection prevalence and tuberculosis reactivation rates among Non-U.S.-born residents in the United States, from the 2011-2012 National Health And Nutrition Examination Survey. J Immigr Minor Health 2021; 23: 806-12. https://doi.org/10.1007/s10903-020-01065-8
Collins JM, Stout JE, Ayers T, Hill AN, Katz DJ, Ho CS, et al. Prevalence of latent tuberculosis infection among non-USBorn persons by country of birth-United States, 2012-2017. Clin Infect Dis 2021; 73: e3468-75. https://doi.org/10.1093/cid/ciaa1662
Chong KC, Leung CC, Yew WW, Zee BCY, Tam GCH, Wang MH, et al. Mathematical modeling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden. Sci Rep 2019 ; 9 : 4869. https://doi.org/10.1038/s41598-019-41256-4
Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface 2008; 5: 653-62. https://doi.org/10.1098/rsif.2007.1138
Hill AN, Becerra J, Castro KG. Modeling tuberculosis trends in the USA. Epidemiol Infect 2012; 140: 1862-72. https://doi.org/10.1017/S095026881100286X
Kim S, de Los Reyes AA 5th, Jung E. Mathematical model and intervention strategies for mitigating tuberculosis in the Philippines. J Theor Biol 2018; 443: 100-12. https://doi.org/10.1016/j.jtbi.2018.01.026
Central TB Division. Ministry of Health & Family Welfare, Government of India. India TB report; 2023. New Delhi: MohFW, GoI; 2023.
Muñoz L, Stagg HR, Abubakar I. Diagnosis and Management of Latent Tuberculosis Infection. Cold Spring Harbor Perspectives Med 2015; 5: a017830. https://doi.org/10.1101/cshperspect.a017830
Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: New alternatives. Front Immunol 2020; 11: 2006. https://doi.org/10.3389/fimmu.2020.02006
Al-Orainey IO. Diagnosis of latent tuberculosis: Can we do better? Ann Thorac Med 2009; 4: 5-9. https://doi.org/10.4103/1817-1737.44778
Yang H, Kruh-Garcia NA, Dobos KM. Purified protein derivatives of tuberculin - Past, present, and future. FEMS Immunol Med Microbiol 2012; 66: 273-80. https://doi.org/10.1111/j.1574-695X.2012.01002.x
Tebruegge M, Bogyi M, Soriano-Arandes A, Kampmann B, Paediatric Tuberculosis Network European Trials Group. Shortage of purified protein derivative for tuberculosis testing. Lancet 2014; 384: 2026. https://doi.org/10.1016/S0140-6736(14)62335-7
Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection lifelong? BMJ 2019; 367 : l5770. https://doi.org/10.1136/bmj.l5770
Goode JV, Upshur R, Grimes MB, Nadpara P. Patient satisfaction with pharmacist-administered Mantoux tuberculin skin test in a community-based pharmacy setting. J Am Pharm Assoc 2019; 59: S77-80.e2. https://doi.org/10.1016/j.japh.2019.04.024
Brien K, Ikram S, Burman M, Kunst H. Barriers and facilitators of a latent tuberculosis screening and treatment program of recent migrants. Eur Respir J 2020; 56 (Suppl 64) : 508. https://doi.org/10.1183/13993003.congress-2020.508
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Prabhakar Bhushan Mishra, Rajendra Prasad Jaiswal, Bharat Bhushan
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
